share_log

HC Wainwright & Co. Initiates Coverage On PaxMedica With Buy Rating, Announces Price Target of $3

HC Wainwright & Co. Initiates Coverage On PaxMedica With Buy Rating, Announces Price Target of $3

HC Wainwright & Co.以買入評級啓動對PaxMedica的保險,宣佈目標股價爲3美元
Benzinga ·  2023/12/04 06:45

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on PaxMedica (NASDAQ:PXMD) with a Buy rating and announces Price Target of $3.

HC Wainwright & Co. 分析師拉古拉姆·塞爾瓦拉朱以買入評級啓動了對PaxMedica(納斯達克股票代碼:PXMD)的報道,並宣佈目標股價爲3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論